bibliographicCitation |
Ito T, Yamamoto K, Furukawa J, Harada K, Fujisawa M, Omura T, Yano I. Association of sunitinib concentration and clinical outcome in patients with metastatic renal cell carcinoma treated with a 2-week-on and 1-week-off schedule. J Clin Pharm Ther. 2022 Jan;47(1):81–8. doi: 10.1111/jcpt.13517. PMID: 34669974. |